Salivary theophylline concentrations in neonates were measured by a homogeneous enzyme immunoassay and compared with serum concentrations. Free serum theophylline concentrations were also compared with salivary concentrations and the values obtained were almost identical. Results using the immunoassay agreed well with those obtained using a high-performance liquid chromatographic procedure (HPLC).
SUMMARY. Salivary theophylline concentrations in neonates were measured by a homogeneous enzyme immunoassay and compared with serum concentrations. Free serum theophylline concentrations were also compared with salivary concentrations and the values obtained were almost identical. Results using the immunoassay agreed well with those obtained using a high-performance liquid chromatographic procedure (HPLC).
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Theophylline is a bronchodilator and respiratory stimulant used in the treatment of asthma and neonatal apnoea. The effectiveness of theophylline in neonatal apnoea is related to its central stimulant effect on the respiratory centre and not to any improvement in lung function. Theophylline concentrations should be monitored closely in premature neonates due to wide betweenpatient variation in drug elimination rates and a narrow therapeutic window.' The toxic effects of theophylline include gastrointestinal disturbances, seizures, tachycardia, arrhythmias, hypokalaemia, hyponatraemia, hyperglycaemia and acidosis."
Conventional methods for measuring the drug in serum measure total theophylline (i.e. protein bound and free). Salivaryconcentrations, however, are thought to represent free theophylline, which is the pharmacologically active form of the drug and can pass through the cell membrane. Theophylline, although a basic lipophilic drug, appears to bind mostly to albumin and alterations in the concentration of albumin can result in significant changes in the unbound fraction of the drug. The estimation of salivary theophylline instead of serum theophylline also avoids the discomfort of blood sampling, does not deplete the intravascular volume and avoids needle-stick injuries.
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The aim of this study was to determine whether theophylline could usefully be measured in saliva.
METHOD
Permission was obtained from the hospital Ethical Committee before embarking on this study and informed consent was obtained from individual parents as necessary. Salivary theophylline concentrations were measured on 20 neonates using the Syva enzyme multiplied immunoassay technique (EMIT) assay (Syva UK, Maidenhead, UK) on a Cobas Bio centrifugal analyser (Roche Products Ltd, Welwyn Garden City, UK). The manufacturer's recommended conditions were used. The salivary theophylline concentrations obtained were compared with serum theophylline concentrations monitored routinely by the laboratory using the same procedure.
The Syva EMIT assay is a homogenous enzyme immunoassay system claimed to be specific for theophylline, although positive interference in patients with renal failure has been reported. 3 The rate of conversion of nicotinamide-adenine dinucleotide (NAD) to NADH (NAD reduced form) is measured spectrophotometrically and related to the concentration of theophylline in the sample.
At King's CollegeHospital infants with neonatal apnoea were given 4 mg theophylline per kg body Tholnpson weight in two divided doses at 1200 h and 2400 h. Blood was taken routinely at 0600 h once a week for the measurement of theophylline concentration. The theophylline was administered orally as an elixir or given intravenously in the form of aminophylline (theophylline ethylene diamine). In this study the gestational age of the neonates varied from 24-28 weeks except for one who was born at 33 weeks. Theophylline treatment was initiated at various times from 1 week to 1~months postnatally.
Saliva was collected at 0900 h using a sterile mucus extractor. The tubing was dipped into powdered citric acid and then inserted into the infant's mouth. Gentle suction was applied to collect approximately 300-500 JLL saliva which was then stored at -20 DC. Before analysis, the samples were thawed and then centrifuged.
In some cases, sufficient serum was available to ultrafilter using a Syva 'Free Level' filter. The concentration of theophylline in the ultrafiltered serum was compared with that in saliva.
The theophylline concentration in a selection of saliva samples was also measured by a highperformance liquid chromatographic (HPLC) procedure as a method comparison. This method required 50 JLL of sample and 8-chlorotheophylline as the internal standard and is detailed in Appendix 1 of the review article by Rowe et al."
Caffeine concentrations were not investigated in this study although caffeine is a significant metabolite of theophylline in the neonate and sometimes can elicit a measurable pharmacological response potentiating that of theophylline.
RESULTS
theophylline level. For this reason standards provided in the kit were used for each assay and specially prepared salivary standards were not used.
Precision
The 5 mg/L salivary standard was measured 10 times. The mean value was 5 '10 mg/L [standard deviation (SD) = O' 095] giving a within-batch coefficient of variation (CV) of 1· 9%.
Comparison of total theophylline concentration in serum with salivary theophylline Figure 1 shows the relationship between salivary theophylline concentration and serum theophylline concentration. The correlation coefficient was 0'77 and the mean ratio of salivary/serum theophylline was O' 58 (SD = 0,135).
Comparison of free theophylline in serum with salivary theophylline Free serum theophylline concentrations were measured in an ultrafIltrate of serum. A correction for binding to the ultrafiltration membrane was obtained by ultrafiltration of four aqueous theophylline standards. The average percentage bound was 10%. The results are presented in Table 1 .
The mean ratio salivary/serum theophylline of 0'58 therefore indicates that approximately 60% of theophylline in serum is free and 40% is protein bound in neonates.
Comparison of EMIT and HPLC methods of salivary theophylline measurement
The results are presented in Table 2 . FIGURE 1. Relationship between total serum theophylline concentration and salivary theophylline concentration (n =20; r = O'77, P< 0'001). 
Standards
Five theophylline standards were prepared in theophyllineand caffeine-free saliva collected from an adult volunteer after stimulation of salivary flow with citric acid. The saliva was frozen to remove mucoproteins, thawed and then centrifuged. The supernatant obtained was used for the preparation of the standards. Pure, powdered theophylline was used to prepare a stock standard solution of 100 mg/L from which a series of standards from 2· 5 to 20 mg/L were prepared. These standards were then run on the Cobas Bio as samples using a standard curve prepared from the kit standards. The mean recovery was 95' 711Jo. The kit standards were prepared by the manufacturer in a matrix very similar to serum and these results show that saliva as a matrix does not affect the measured TABLE 
Comparison of enzyme multiplied immunoassay technique (EMIT) and high-performance liquid chromatography (HPLC) methods of salivary theophylline measurements
The mean saliva/serum ratio of 0·58 found in this study agrees well with the figure of O·57 found This discrepancy could be explained because the last two workers did not collect saliva after stimulation which, according to Knott et al., maximizes flow rate and minimizes saliva/ serum variation. When saliva enters the mouth and comes into contact with air, carbon dioxide, formed from carbonic acid in solution, is lost and saliva pH rises. Changes in salivary pH have been shown to be wholly dependent on changes in the flow rate and hence the maximized flow rate after stimulation minimizes the pH variation.
The observed range of saliva/serum ratios could also be due to variable protein binding. Neonatal serum protein differs from that found in children and adults both quantitatively and qualitativelyt-i-high serum concentrations of free fatty acids, unconjugated bilirubin and steroids in the neonate can all compete with drugs at protein binding sites. Variations in blood pH as small as 0·2 may also provoke significant fluctuations in plasma protein binding." This degree of pH fluctuation can often be observed in the preterm neonate with apnoea. Thus, theophylline protein binding can be influenced by hyperbilirubinaemia and respiratory status. The excellent agreement between salivary theophylline concentrations and measured free theophylline in serum in this study indicates that salivary concentrations are a good measure of the free, pharmacologically active theophylline in the body fluids.
The relatively small number of patients sampled in this study means it would be inappropriate to predict a salivary theophylline therapeutic range for neonates. Khanna et al," found that when the neonatal salivary concentrations of theophylline were less than 8 mg/L, the serum concentrations did not exceed the upper limit of the therapeutic range is higher, approximately 60% being protein bound. The lower therapeutic window for total theophylline concentrations in neonates relative to the adult could be the result of the availability of a higher free drug concentration at the receptor site due to the lower protein-drug binding. Also the pharmacodynamic effect required in the neonate [central nervous system (CNS) stimulation] is different to that required in the adult (bronchodilation). These differences are also relevant to the different therapeutic window.
In this study the ward routine prevented the simultaneous collection of saliva and blood samples and the saliva was collected 3 h after the blood. However, any discrepancy from this source should be small due to the very long half Recently, two new devices have come onto the market for the collection of saliva. The first is called a 'salivette' (Sarstedt Ltd, Leicester, UK).12 This device comprises a cylindrical cotton wool swab placed into an insert suspended into a longer conical centrifuge vessel. There are two types: the cotton wool swab of one contains citric acid, the other does not. Saliva is collected by asking the patient to chew on the swab for 45 s, placing the swab back into the suspended insert, and then freezing the capped salivette. The other device is a 'SalivaSac' (BioQuant Inc., Ann Arbor, MI, USA).13 This accumulates a saliva ultrafiltrate as the sac is moved around in the mouth, using citric acid to stimulate salivary flow. The salivette may possibly have a use in the collection of saliva from neonates although, of course, the patient would not be able to chew and the volume of saliva obtained would be much smaller than that from an older child or adult.
CONCLUSION
Measurements of theophylline in saliva give comparable information to measurements of free theophylline in serum. Sample collection is non-invasive, and measurements reflect the pharmacologically active form of the drug, avoiding problems caused by variable protein binding in serum.
